Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.
Osvaldo Ulises GarayGonzalo Germán GuiñazúYolanda Patricia AdamczukCristina DuboscqPublished in: PharmacoEconomics - open (2022)
Anticoagulation clinics are estimated to be cost effective and generate notable savings in the treatment of patients on long-term oral anticoagulant therapy when compared with non-AC settings. These savings are considerably higher when POC devices are added as part of the patient management, due to lower laboratory technician costs per INR determination.
Keyphrases
- atrial fibrillation
- venous thromboembolism
- end stage renal disease
- primary care
- newly diagnosed
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- prognostic factors
- mesenchymal stem cells
- bone marrow
- patient reported outcomes
- molecularly imprinted
- cell therapy
- patient reported
- simultaneous determination